Research progress of single nucleotide polymorphisms and immune cells in diabetic kidney disease

doi:10.16352/j.issn.1001-6325.2022.02.019

Abstract

Abstract: Diabetic kidney disease has obvious family aggregation and ethnic differences, some single nucleotide polymorphisms (SNPs) related to the susceptibility of diabetic kidney disease have been identified, especially engulfment and cell motility 1 (ELMO1) and solute carrier family 12 member 3(SLC12A3), which are related to the development of diabetic kidney disease in Chinese population. Meanwhile, inflammation plays a key role in the occurrence and development of diabetic kidney disease, including T cell and type-2 innate lymphoid cell(ILC2) promote chronic inflammatory response and fibrosis of kidney by secreting inflammatory factors.

Key words: diabetic kidney disease, the single nucleotide polymorphisms, chronic inflammatory reaction

CLC Number:

GUO Meng-ran, MIN Hang, YE Yue, XU Xiao-shuang, ZHEN Dong-hu. Research progress of single nucleotide polymorphisms and immune cells in diabetic kidney disease[J]. Basic & Clinical Medicine, 2022, 42(2): 335-339.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.02.019

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I2/335

References

[1]中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志,2018,38:292-344.
[2]刘国强,谢超,洪天配. 美国临床内分泌医师协会2015年版糖尿病综合管理临床实践指南的解读[J]. 糖尿病天地(临床),2016,10:146-149.
[3]Tziastoudi M, Stefanidis I, Zintzaras E. The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies[J]. Clin Kidney J, 2020, 13:768-781.
[4]Hathaway CK, Chang AS, Grant R, et al. High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy[J]. Proc Natl Acad Sci U S A, 2016, 113:2218-2222.
[5]Mehrabzadeh M, Pasalar P, Karimi M, et al. Association between ELMO1 gene polymorphisms and diabetic nephropathy in an Iranian population[J]. J Diabetes Metab Disord, 2015, 15:43.doi:10.1186/s40200-016-0265-3.
[6]Bodhini D, Chidambaram M, Liju S, et al. Association of rs11643718 SLC12A3 and rs741301 ELMO1 variants with diabetic nephropathy in south indian population[J]. Ann Hum Genet, 2016, 80:336-341.
[7]Yahya MJ, Ismail PB, Nordin NB, et al. Association of CCL2, CCR5, ELMO1, and IL8 polymorphism with diabetic nephropathy in malaysian type 2 diabetic patients[J]. Int J Chronic Dis, 2019, 2019:2053015.doi:10.1155/2019/2053015.
[8]Hou Y, Gao Y, Zhang Y, et al. Interaction between ELMO1 gene polymorphisms and environment factors on susceptibility to diabetic nephropathy in Chinese Han population[J]. Diabetol Metab Syndr, 2019, 11:97.doi:10.1186/s13098-019-0492-0.
[9]An C, Liang J, Zhang K, et al. Polymorphisms in the SLC12A3 gene encoding sodium-chloride cotransporter are associated with hypertension: a family-based study in the mongolian population[J]. Kidney Blood Press Res, 2016, 41:18-28.
[10]De La Cruz-Cano E, Jiménez-González CDC, Morales-García V, et al. Arg913Gln variation of SLC12A3 gene is associated with diabetic nephropathy in type 2 diabetes and Gitelman syndrome: a systematic review[J]. BMC Nephrol, 2019, 20:393.doi:10.1196/s12882-019-1590-9.
[11]Abu Seman N, He B, Ojala JR, et al. Genetic and biological effects of sodium-chloride cotransporter (SLC12A3) in diabetic nephropathy[J]. Am J Nephrol, 2014, 40:408-416.
[12]Zhang R, Zhuang L, Li M, et al. Arg913Gln of SLC12A3 gene promotes development and progression of end-stage renal disease in Chinese type 2 diabetes mellitus[J]. Mol Cell Biochem, 2018, 437:203-210.
[13]Hickey FB, Martin F. Role of the immune system in diabetic kidney disease[J]. Curr Diab Rep, 2018, 18:20.doi:org/10.1007/s11892-018-0984-6.
[14]Tang PC, Zhang YY, Chan MK, et al. The emerging role of innate immunity in chronic kidney diseases[J]. Int J Mol Sci, 2020, 21.doi:10.3390/ijms21114018.
[15]Araújo LS, Torquato BGS, Da Silva CA, et al. Renal expression of cytokines and chemokines in diabetic nephropathy[J]. BMC Nephrol, 2020, 21:308. doi:10.1186/s12882-020-01960-0.
[16]Ma C, Greten TF. Commensal bacteria (ab)use CD8(+) T cells to induce insulin resistance[J]. Sci Immunol, 2017, 2.doi:10.1126/sciimmunol.aan1473.
[17]Zhang N, Tai J, Qu Z, et al. Increased CD4(+)CXCR5(+)T follicular helper cells in diabetic nephropathy[J]. Autoimmunity, 2016, 49:405-413.
[18]Abouzeid S, Sherif N. Role of alteration in Treg/Th17 cells' balance in nephropathic patients with Type 2 diabetes mellitus[J]. Electron Physician, 2015, 7:1613-1618.
[19]Ebbo M, Crinier A, Vély F, et al. Innate lymphoid cells: major players in inflammatory diseases[J]. Nat Rev Immunol, 2017, 17:665-678.
[20]Kato A. Group 2 innate lymphoid cells in airway diseases[J]. Chest, 2019, 156:141-149.
[21]Mikami Y, Takada Y, Hagihara Y, et al. Innate lymphoid cells in organ fibrosis[J]. Cytokine Growth Factor Rev, 2018, 42:27-36.
[22]Cao Q, Wang Y, Niu Z, et al. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury[J]. J Am Soc Nephrol, 2018, 29:961-976.
[23]Kabata H, Moro K, Koyasu S. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms[J]. Immunol Rev, 2018, 286:37-52.
[24]邱书娟,孙秀菊,李香玲.银杏叶提取物减轻糖尿病大鼠肾缺血再灌注损伤[J].基础医学与临床,2019,39:1729-1734.
[25]路萍,徐芸芸,苏兆亮.糖尿病肾病患者Ⅱ型固有淋巴细胞活性增强参与代谢综合征的组分聚集状态形成[J].细胞与分子免疫学杂志, 2017, 33:820-825.
[26]Liu C, Qin L, Ding J, et al. Group 2 innate lymphoid cells participate in renal fibrosis in diabetic kidney disease partly via TGF-β1 signal pathway[J]. J Diabetes Res, 2019, 2019:8512028.doi:10.1155/2019/8512028.